retatrutide companies Retatrutide, Eli Lilly's new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials Buy Retatrutide 20mg | Order

Zhu H, Yi X, He M, Wu S, Li M, Gao S

Aqualyx is a non-surgical treatment designed to tackle fat deposits directly through injections

Intravenous edaravone treatment in ALS and survival: an exploratory, retrospective, administrative claims analysis

Participants received detailed questionnaires about any symptoms experienced between visits, and study staff conducted physical examinations to document observable reactions

Priority Applications (6) Applications Claiming Priority (4) Publications (1) Family ID=35462732 Family Applications (1) Country Status (8) Cited By (3) Families Citing this family (23) Citations (3) Family Cites Families (35) 2005 2005-05-26 US US11/139,730 patent/US7235625B2/en not_active Expired - Lifetime 2005-05-27 WO PCT/US2005/018739 patent/WO2005117935A1/en not_active Ceased 2005-05-27 JP JP2007515390A patent/JP2008500369A/en not_active Withdrawn 2005-05-27 CA CA002568218A patent/CA2568218A1/en not_active Abandoned 2005-05-27 BR BRPI0510862-4A patent/BRPI0510862A/en not_active Application Discontinuation 2005-05-27 AU AU2005249474A patent/AU2005249474A1/en not_active Abandoned 2005-05-27 KR KR1020067027495A patent/KR20070036079A/en not_active Withdrawn 2005-05-27 EP EP05761072A patent/EP1755638A4/en not_active Withdrawn